RhoA/Rho‐Kinase as a Therapeutic Target for the Male Urogenital Tract

This review focuses on our current understanding of the role of the RhoA/Rho‐kinase pathway in the regulation of the male urogenital system. Rho‐kinase inhibitors may evolve into an important pharmacologic option in the future treatment of urogenital system disorders. Gur S, Kadowitz PJ, and Hellstrom WJG. RhoA/Rho‐kinase as a therapeutic target for the male urogenital tract.